COLORRETAL
Moderator
Discussant
Discussant
08:00 - 08:20
08:20 - 08:40
15/10/2015
08:40 - 09:00
09:00 - 09:20
09:20 - 09:30
09:30 - 09:40
09:40 - 10:00
Discussant
Discussant
Discussant
Moderator
10:15 - 10:35
10:35 - 10:55
15/10/2015
10:55 - 11:15
11:15 - 11:35
11:35 - 11:55
11:55 - 12:15
MODULE 1
Claudio de Almeida Quadros
Ricardo Cotta
Sérgio Nahas
Watch and wait approach?
Neoadjuvant chemoradiotherapy and TME. Multidisciplinary treatment optimization for low and intermediate risk rectal cancer
Non-operative management of rectal cancer
Japonese protocol for rectal cancer treatment
What a Radiotherapist would have to say?
What a Clinical Oncologist would have to say?
Discussion
MODULE 2
Armando Melani
Raul Cutait
Ícaro Thiago De Carvalho
Jose Humberto Simoes Correa
MRI in rectal cancer staging
Local excision for early rectal cancer: technique presentation
Locally advanced rectal cancer, therapeutic approach, surgical strategy and results
Adjuvant treatment for rectal cancer. Qual o estadiamento deve ser considerado após radioquimioterapia neoadjuvante, o clínico ou o
patológico? É indicado tratamento quimioterápico adjuvante em estádio pT3-4N0 após tratamento neoadjuvante para
adenocarcinoma de reto?
Reduction of infection related complications with imune preparations
Robotic surgery for rectal cancer
Speaker
Speaker
Speaker
Speaker
Speaker
Speaker
Geerard Beets
George Chang
Julio Garcia Aguilar
Yukihide Kanemitsu
Arthur Accioly Rosa
Paulo Hoff
Speaker
Speaker
Speaker
Geerard Beets
Julio Garcia Aguilar
Theo Wiggers
Palestrante Paulo Hoff
Speaker
Speaker
José Aguilar Nascimento
George Chang
COLORRETAL
Discussant
Discussant
Moderator
14:10 - 14:30
15/10/2015 14:30 - 14:50
14:50 - 15:10
15:10 - 15:30
15:30 - 15:50
15:50 - 16:10
Discussant
Discussant
Moderator
16:25 - 16:40
16:40 - 17:00
15/10/2015 17:00 - 17:10
17:10 - 17:20
17:20 - 17:40
17:40 - 18:00
18:00 - 18:15
18:15 - 18:25
MÓDULO 3
André Maciel da Silva
Aknar Calabrich
Geraldo José Nascimento
Surgical technique in colon cancer
Are there any advantages of D3 lymphadenectomy for right colon cancer? A view from Japan
What are the limits for minimal invasive colectomy?
Quando considerar uma síndrome genética em paciente com CCR?
Long term results of colorectal cancer treatment in Japan
Discussão
MODULE 4
Lauzamar Roge Salomão Junior
Adriano Carvalho
Jose Humberto Simoes Correa
Informações essenciais que cirurgião precisa saber as terapias alvo?
What to do in retroperitoneal and/or pelvic lymph node recurrence? Surgical oncologist point of view
Recidiva linfonodal retroperitoneal e/ou pélvica, o que fazer? Visão do Radioterapêuta
Recidiva linfonodal retroperitoneal e/ou pélvica, o que fazer? - Visão do Oncologista Clínico
IORT for advanced colorectal cancers
Treating recurrent colorectal disease
Papel da linfadenectomia do hilo hepático no tratamento das recidivas hepaticas
Debate
Speaker
Speaker
Speaker
Palestrante
Speaker
George Chang
Yukihide Kanemitsu
Julio Garcia Aguilar
Jose Humberto Simoes Correa
Yukihide Kanemitsu
Palestrante
Speaker
Palestrante
Palestrante
Speaker
Speaker
Palestrante
A Definir
Yukihide Kanemitsu
Ícaro Thiago De Carvalho
Roberto Gil
Prajnan Das
Julio Garcia Aguilar
Paulo Herman
COLORRETAL
Discussant
Discussant
Moderator
08:00 - 08:20
08:20 - 08:40
16/10/2015 08:40 - 09:00
09:00 - 09:20
09:20 - 09:40
09:20 - 09:40
09:20 - 09:40
09:40 - 10:00
Discussant
Discussant
Discussant
Moderator
16/10/2015
10:15 - 10:35
10:35 - 10:55
10:55 - 11:15
11:15 - 11:35
11:35 - 11:55
11:55 - 12:15
MODULE 5
A Definir
Mario Feitosa Falcao
Eduardo Miranda Brandao
Qual a melhor sequência de tratamento?
Managing of extra-hepatic disease in setting of resectable CRLM
Robotic pulmonary resection for CRLM
Are colorectal metastasis to retroperitoneal and pelvic nodes M1 or N3?
Is there indication of HIPEC in patients with ressectable extra-peritoneal disease?
Is there indication of HIPEC in patients with ressectable extra-peritoneal disease?
Is there indication of HIPEC in patients with ressectable extra-peritoneal disease?
Debate
MODULE 1
Bruno José De Queiroz Sarmento
Odilon De Souza Filho
Carlos Frederico Benevides
Claudio De Almeida Quadros
Why Clinical Oncologists still do not indicate HIPEC for colorrectalç carcinomatosis? Results of systemic chemotherapy for peritoneal
carcinomasis from CCR
Results of surgical citorreduction + HIPEC for peritoneal carcinomasis from CCR
Equivalence and difference between liver metastasis and peritoneal metastasis from colorectal cancer
Future Directions of Colorectal Cancer with Peritoneal Dissemination
Curative treatment of colorectal peritoneal carcinomatosis: where are we?
Debate
Palestrante
Speaker
Speaker
Speaker
Speaker
Speaker
Speaker
Eduardo de Moraes
Timothy Pawlik
Jae Kim
Yukihide Kanemitsu
Dominique Elias
Jesus Esquivel
Victor Jilbert Verwaal
Speaker
Celso Abdon Mello
Speaker
Speaker
Speaker
Speaker
Victor Jilbert Verwaal
Dominique Elias
Jesus Esquivel
Dominique Elias